Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,481 | 56 | 95.8% |
| Education | $65.00 | 2 | 4.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merz North America, Inc. | $352.37 | 4 | $0 (2023) |
| ABBVIE INC. | $338.65 | 22 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $149.54 | 8 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $132.71 | 3 | $0 (2019) |
| TherapeuticsMD, Inc. | $129.10 | 2 | $0 (2019) |
| PFIZER INC. | $118.46 | 3 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $81.53 | 3 | $0 (2021) |
| Astellas Pharma US Inc | $43.31 | 2 | $0 (2019) |
| Sanofi Pasteur Inc. | $40.24 | 2 | $0 (2018) |
| GlaxoSmithKline, LLC. | $33.02 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $156.39 | 13 | ABBVIE INC. ($130.74) |
| 2023 | $321.02 | 7 | Merz North America, Inc. ($141.51) |
| 2022 | $60.27 | 3 | ABBVIE INC. ($60.27) |
| 2021 | $71.23 | 3 | Boehringer Ingelheim Pharmaceuticals, Inc. ($28.91) |
| 2020 | $137.97 | 3 | MERZ NORTH AMERICA, INC. ($110.53) |
| 2019 | $364.88 | 9 | TherapeuticsMD, Inc. ($129.10) |
| 2018 | $236.87 | 12 | Merck Sharp & Dohme Corporation ($120.44) |
| 2017 | $197.17 | 8 | MERZ NORTH AMERICA, INC. ($59.00) |
All Payment Transactions
58 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $6.73 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $10.99 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $6.36 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/25/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $6.09 | General |
| Category: FACIAL AESTHETICS | ||||||
| 05/01/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: FACIAL AESTHETICS | ||||||
| 04/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.50 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $2.65 | General |
| Category: FACIAL AESTHETICS | ||||||
| 03/29/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $4.64 | General |
| Category: FACIAL AESTHETICS | ||||||
| 03/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: NEUROSCIENCE | ||||||
| 02/29/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.03 | General |
| Category: FACIAL AESTHETICS | ||||||
| 01/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: NEUROSCIENCE | ||||||
| 01/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: PAIN | ||||||
| 12/21/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/28/2023 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $141.51 | General |
| Category: Dermatology | ||||||
| 10/04/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: PAIN | ||||||
| 08/31/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: FACIAL AESTHETICS | ||||||
| 08/22/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $78.80 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 05/25/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Diabetes | ||||||
| 03/15/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: NEUROSCIENCE | ||||||
| 03/15/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: NEUROSCIENCE | ||||||
| 04/28/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: NEUROSCIENCE | ||||||
| 03/24/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 292 | 382 | $42,935 | $28,116 |
| 2022 | 9 | 316 | 434 | $42,710 | $27,984 |
| 2021 | 6 | 255 | 314 | $33,955 | $22,430 |
| 2020 | 6 | 272 | 346 | $32,820 | $19,503 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 66 | 66 | $13,200 | $9,264 | 70.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 80 | 136 | $13,625 | $8,522 | 62.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 64 | 84 | $10,600 | $7,265 | 68.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 22 | 23 | $1,570 | $1,539 | 98.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 38 | 50 | $3,250 | $850.40 | 26.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 22 | 23 | $690.00 | $676.20 | 98.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 59 | 59 | $11,785 | $8,482 | 72.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 66 | 103 | $10,300 | $6,965 | 67.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 58 | 79 | $9,925 | $6,917 | 69.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 12 | 12 | $2,400 | $2,185 | 91.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 20 | 21 | $1,275 | $1,252 | 98.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 59 | 73 | $4,745 | $1,153 | 24.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 20 | 21 | $630.00 | $618.60 | 98.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 11 | 33 | $990.00 | $368.79 | 37.3% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 11 | 33 | $660.00 | $43.09 | 6.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 84 | 124 | $12,400 | $7,656 | 61.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 44 | 44 | $8,800 | $6,451 | 73.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 58 | 70 | $8,750 | $6,327 | 72.3% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 18 | 18 | $900.00 | $900.00 | 100.0% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 32 | 39 | $2,535 | $731.50 | 28.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 19 | 19 | $570.00 | $364.61 | 64.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 80 | 130 | $13,000 | $7,098 | 54.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 41 | 54 | $6,750 | $4,718 | 69.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 33 | 33 | $6,600 | $4,252 | 64.4% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 37 | 37 | $1,820 | $1,818 | 99.9% |
About Dr. Kathleen Gallaher, M.D
Dr. Kathleen Gallaher, M.D is a Family Medicine healthcare provider based in Villa Park, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114034808.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kathleen Gallaher, M.D has received a total of $1,546 in payments from pharmaceutical and medical device companies, with $156.39 received in 2024. These payments were reported across 58 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,481).
As a Medicare-enrolled provider, Gallaher has provided services to 1,135 Medicare beneficiaries, totaling 1,476 services with total Medicare billing of $98,032. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Villa Park, CA
- Active Since 08/25/2006
- Last Updated 03/07/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1114034808
Products in Payments
- Xeomin (Biological) $200.51
- BOTOX (Biological) $140.96
- VRAYLAR (Drug) $120.21
- BIJUVA (Drug) $119.57
- GARDASIL (Biological) $119.21
- FARXIGA (Drug) $117.38
- JARDIANCE (Drug) $81.53
- PAXLOVID (Drug) $78.80
- Androgel (Drug) $55.16
- MENACTRA (Drug) $40.24
- NURTEC ODT (Drug) $39.66
- UBRELVY (Drug) $37.51
- SHINGRIX (Biological) $33.02
- ThinPrep (Device) $24.16
- VESICARE (Drug) $21.87
- MYRBETRIQ (Drug) $21.44
- TRINTELLIX (Drug) $20.00
- HawkOne (Device) $19.64
- TOUJEO (Drug) $19.09
- Ozempic (Drug) $16.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Villa Park
Dr. Anthony Lin, Md, MD
Family Medicine — Payments: $14,926
Dr. Eyad Homedi, M.d, M.D
Family Medicine — Payments: $4,554
Dr. Linda Warner, D.o, D.O
Family Medicine — Payments: $1,858
Dr. Mohammed Samiruddin, M.d, M.D
Family Medicine — Payments: $1,472
Dr. Soha Sattar, M.d, M.D
Family Medicine — Payments: $156.73
Richard Novak, M.d, M.D
Family Medicine — Payments: $55.10